{"id":"W2129669150","doi":"10.1016/s1474-4422(14)70088-2","title":"Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Biological Activity of Diterpenoids and Biflavonoids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":289,"is_retracted":false,"has_abstract":false,"ca_institutions":"Paladin Labs (Canada); Arbutus Biopharma (Canada); University of Toronto","funders":"National Institute on Aging; Allos Therapeutics","keywords":"Progressive supranuclear palsy; Placebo; Double blind; Physical medicine and rehabilitation; Medicine; Physical therapy; Internal medicine; Disease; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001441737,0.002010705,0.00513005,0.0004993203,0.0005084038,0.001150926,0.001127933,0.002785415,0.007147531],"category_scores_gemma":[0.00137092,0.0007309773,0.002232952,0.0005108353,0.001357793,0.001444801,0.0003731811,0.003465493,0.00120959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006358299,"about_ca_system_score_gemma":0.001051402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001395089,"about_ca_topic_score_gemma":0.002503142,"domain_scores_codex":[0.9995479,0.0001763274,0.00003388074,0.00009666768,0.00003580373,0.0001094376],"domain_scores_gemma":[0.9993865,0.0002157645,0.0001047573,0.00004179337,0.00004633805,0.0002048254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9805338,0.001975107,0.000263006,0.001097187,0.0009666221,0.00007422776,0.00004624545,0.0001801879,0.002252056,0.0001196813,0.000658253,0.01183351],"study_design_scores_gemma":[0.9797159,0.01869872,0.000565932,0.00003915271,0.0002786668,0.00003206621,0.00002056206,0.0001052014,0.0001250241,0.0001076637,0.0003004399,0.00001067444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9648028,0.02191513,0.001264932,0.001265671,0.001865183,0.00370187,0.001420501,0.0003012242,0.003462764],"genre_scores_gemma":[0.971819,0.01237936,0.001762227,0.001952719,0.0008100646,0.004383076,0.001383471,0.00004339748,0.00546671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007147531,"threshold_uncertainty_score":0.02391082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01814572450016573,"score_gpt":0.2714453636723508,"score_spread":0.2532996391721851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}